The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

Bird flu isn’t part of the “quad-demic” of viruses circulating through the country this winter—COVID, seasonal flu, ...

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health ...

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

The current public-health risk is low, but the CDC is working with states to monitor people with animal exposure.

The number of bird flu cases in Central Massachusetts is relatively low, compared to a swath of the state that runs from ...

"HHS awards $590m to Moderna for mRNA ‘flu vax development" was originally created and published by Pharmaceutical Technology ...

The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of ...